Jean-Luc Reny Selected Research

Jean-Luc Reny Research Topics

Disease

10	Hemorrhage 01/2022 - 10/2010
10	Acute Coronary Syndrome 11/2020 - 02/2008
9	COVID-19 03/2024 - 07/2020
8	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 08/2003
7	Thrombosis (Thrombus) 05/2022 - 02/2004
5	Pneumonia (Pneumonitis) 09/2022 - 01/2018
4	Stroke (Strokes) 01/2022 - 01/2016
4	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 06/2012
3	Chronic Renal Insufficiency 10/2023 - 07/2018
3	Myocardial Infarction 01/2022 - 11/2020
3	Hypertension (High Blood Pressure) 10/2020 - 06/2012
3	Heart Failure 10/2019 - 03/2006
3	Ischemic Stroke 01/2018 - 01/2016
2	Venous Thromboembolism 08/2023 - 04/2003
2	Inflammation (Inflammations) 09/2022 - 11/2021
2	Venous Thrombosis (Deep-Vein Thrombosis) 05/2022 - 10/2007
2	Critical Illness (Critically Ill) 05/2022 - 03/2002
2	Atherosclerosis 11/2013 - 12/2003
2	Dyspnea (Shortness of Breath) 01/2009 - 03/2006
1	Adrenal Insufficiency (Adrenal Gland Hypofunction) 01/2023
1	Drug-Related Side Effects and Adverse Reactions 01/2023
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 11/2022
1	Pulmonary Embolism 05/2022
1	Coronary Disease (Coronary Heart Disease) 01/2022
1	Injection Site Reaction 01/2022
1	Dementia (Dementias) 12/2021
1	Embolism (Embolus) 01/2019
1	Neoplasms (Cancer) 01/2019
1	Pleural Effusion (Pleural Effusions) 10/2018
1	HIV Infections (HIV Infection) 10/2018
1	Autoimmune Diseases (Autoimmune Disease) 10/2018
1	Latent Tuberculosis 05/2015

Drug/Important Bio-Agent (IBA)

8	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 04/2021 - 10/2010
7	AnticoagulantsIBA 01/2022 - 10/2010
7	Clopidogrel (Plavix)FDA Link 01/2020 - 04/2009
5	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2016 - 02/2008
3	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2023 - 04/2015
3	Ritonavir (Norvir)FDA Link 01/2023 - 10/2018
3	C-Reactive ProteinIBA 09/2022 - 03/2002
3	Biomarkers (Surrogate Marker)IBA 09/2022 - 01/2020
3	Immunoglobulin M (IgM)IBA 09/2022 - 07/2020
3	pro-brain natriuretic peptide (1-76)IBA 12/2021 - 03/2006
3	Adenosine Diphosphate (ADP)IBA 01/2020 - 08/2003
3	Prasugrel Hydrochloride FDA Link 10/2018 - 11/2013
3	omega-Chloroacetophenone (Mace)IBA 04/2016 - 06/2012
2	CreatinineIBA 10/2023 - 01/2009
2	Enoxaparin (Lovenox)FDA LinkGeneric 08/2023 - 05/2022
2	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2023 - 12/2020
2	Lopinavir FDA Link 01/2023 - 12/2020
2	NeopterinIBA 09/2022 - 01/2020
2	Serum Amyloid A Protein (Serum Amyloid A)IBA 09/2022 - 01/2020
2	Cytochrome P-450 CYP2C19IBA 11/2021 - 03/2013
2	Immunoglobulin G (IgG)IBA 10/2020 - 07/2020
2	Peptides (Polypeptides)IBA 01/2009 - 03/2006
1	GlucocorticoidsIBA 01/2023
1	SteroidsIBA 01/2023
1	pembrolizumabIBA 11/2022
1	Immune Checkpoint InhibitorsIBA 11/2022
1	Phosphorylcholine (Phosphocholine)IBA 09/2022
1	Peroxidase (Myeloperoxidase)IBA 09/2022
1	InterleukinsIBA 09/2022
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 09/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 05/2022
1	Dacarbazine (DIC)FDA LinkGeneric 05/2022
1	fibrin fragment D (D-dimer)IBA 05/2022
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022
1	EnzymesIBA 01/2022
1	PCSK9 InhibitorsIBA 01/2022
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2022
1	Ezetimibe (Zetia)FDA Link 01/2022
1	Interleukin-8 (Interleukin 8)IBA 12/2021
1	Cytochrome P-450 CYP3AIBA 11/2021
1	Protein Isoforms (Isoforms)IBA 11/2021
1	Cytochrome P-450 CYP1A2 (CYP1A2)IBA 11/2021
1	Interleukin-6 (Interleukin 6)IBA 11/2021
1	CytochromesIBA 11/2021
1	CholesterolIBA 10/2020
1	ProcalcitoninIBA 01/2020
1	Angiotensin Receptor AntagonistsIBA 10/2019
1	Enalapril FDA LinkGeneric 10/2019
1	sacubitril and valsartan sodium hydrate drug combinationIBA 10/2019
1	Neprilysin (Neutral Endopeptidase)IBA 10/2019
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 10/2019
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2019
1	CobicistatIBA 10/2018
1	Cytochrome P-450 CYP3A InhibitorsIBA 10/2018
1	Antinuclear AntibodiesIBA 10/2018
1	AutoantibodiesIBA 10/2018
1	TNF Receptor-Associated Factor 3IBA 01/2016

Therapy/Procedure

12	Therapeutics 12/2023 - 10/2010
4	Percutaneous Coronary Intervention 11/2020 - 02/2012
3	Stents 03/2015 - 03/2013
2	Contraindications 01/2023 - 12/2020
2	Injections 01/2022 - 01/2019
1	Artificial Respiration (Mechanical Ventilation) 03/2024
1	Length of Stay 12/2020
1	Investigational Therapies (Experimental Therapy) 12/2020